Nicole Murphy - Biogen Head Technology
| IDP Stock | EUR 155.25 1.75 1.11% |
Insider
Nicole Murphy is Head Technology of Biogen Inc
| Phone | 617 679 2000 |
| Web | https://www.biogen.com |
Biogen Management Efficiency
The company has return on total asset (ROA) of 0.0778 % which means that it generated a profit of $0.0778 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2433 %, meaning that it generated $0.2433 on every $100 dollars invested by stockholders. Biogen's management efficiency ratios could be used to measure how well Biogen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jennifer Mauer | Merck Co | N/A | |
| Nancy Grygiel | Amgen Inc | 55 | |
| Rodrigo Santos | Bayer Aktiengesellschaft | 50 | |
| Heiko Schipper | Bayer Aktiengesellschaft | 54 | |
| Peter Griffith | Amgen Inc | 64 | |
| BerndPeter Bier | Bayer Aktiengesellschaft | 56 | |
| Esteban Santos | Amgen Inc | 55 | |
| Michael Preuss | Bayer Aktiengesellschaft | N/A | |
| Claudia Bockstiegel | Roche Holding Ltd | 59 | |
| Peter Dannenbaum | Merck Co | N/A | |
| Jennifer Zachary | Merck Co | 45 | |
| Bruno Eschli | Roche Holding Ltd | N/A | |
| Minoru Kikuoka | Astellas Pharma | N/A | |
| Collette Taylor | Astellas Pharma | 60 | |
| Arvind Sood | Amgen Inc | N/A | |
| Wolfgang Nickl | Bayer Aktiengesellschaft | 54 | |
| Johannes MD | Roche Holding Ltd | 66 | |
| Werner Baumann | Bayer Aktiengesellschaft | 61 | |
| Catherine Levitt | Astellas Pharma | N/A | |
| Sarena Lin | Bayer Aktiengesellschaft | 52 | |
| Stig Ogata | Astellas Pharma | N/A | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.0778 |
Biogen Inc Leadership Team
Elected by the shareholders, the Biogen's board of directors comprises two types of representatives: Biogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biogen. The board's role is to monitor Biogen's management team and ensure that shareholders' interests are well served. Biogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Viehbacher, CEO Pres | ||
| Robin Kramer, VP Officer | ||
| Sanjay Jariwala, VP Medical | ||
| Ginger Gregory, Ex Officer | ||
| Anabella Villalobos, Head Sciences | ||
| Susan Esq, Chief VP | ||
| Michael CPA, Ex CFO | ||
| Natacha Gassenbach, Chief Affairs | ||
| Nicole Murphy, Head Technology | ||
| Michael Hencke, Head Relations |
Biogen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.0778 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 41.13 B | |||
| Shares Outstanding | 144.49 M | |||
| Shares Owned By Insiders | 0.68 % | |||
| Shares Owned By Institutions | 89.93 % | |||
| Price To Earning | 14.27 X | |||
| Price To Book | 3.24 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Biogen Stock
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.